Retracted: Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer
- PMID: 38550151
- PMCID: PMC10973245
- DOI: 10.1155/2024/9823079
Retracted: Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer
Abstract
[This retracts the article DOI: 10.1155/2022/2587120.].
Copyright © 2024 BioMed Research International.
Retraction of
-
Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.Biomed Res Int. 2022 Apr 18;2022:2587120. doi: 10.1155/2022/2587120. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9823079. doi: 10.1155/2024/9823079. PMID: 35496037 Free PMC article. Retracted.
Similar articles
-
Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.Biomed Res Int. 2022 Apr 18;2022:2587120. doi: 10.1155/2022/2587120. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9823079. doi: 10.1155/2024/9823079. PMID: 35496037 Free PMC article. Retracted.
-
Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.Oxid Med Cell Longev. 2023 Aug 2;2023:9795318. doi: 10.1155/2023/9795318. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 37565171 Free PMC article.
-
Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.Biomed Res Int. 2024 Mar 20;2024:9851737. doi: 10.1155/2024/9851737. eCollection 2024. Biomed Res Int. 2024. PMID: 38549990 Free PMC article.
-
Retracted: Identification of the Novel Methylated Genes' Signature to Predict Prognosis in INRG High-Risk Neuroblastomas.J Oncol. 2022 Dec 28;2022:9846323. doi: 10.1155/2022/9846323. eCollection 2022. J Oncol. 2022. PMID: 36618072 Free PMC article.
-
Retracted: Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer.Evid Based Complement Alternat Med. 2023 Jun 21;2023:9831949. doi: 10.1155/2023/9831949. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37388014 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources